A useful source answers the same question as the claim beside it. A license record answers a licensing question. A price advertisement answers what was advertised on a given date. Neither gives a verdict on the whole care plan. When an offer cites a source, ask what that source actually establishes and what remains to be checked for you.
Match the document to the question
In its explanation checked November 3, 2026, FDA separates product approval from having a National Drug Code entry. That code is a product identifier in a government directory. FDA also distinguishes facility registration from approval of the facility's products. These are common examples of a real record being asked to prove too much. Ask for the approval record when the claim is approval, and use a state license record when the question is a license to practice.
- For a medicine claim, keep the product name and its form (an injection, tablet, or other preparation) beside the document. An ingredient listing is not the finished-product record.
- For a clinician (doctor, physician assistant, or nurse practitioner) or pharmacy, match the full name and license type. Use the state search rather than relying on a badge image.
- For a quoted price, ask what was included, what conditions applied, and when the figure was observed. Keep that date with the amount.
Source notes
The source below supports the point above, within its stated limits.
FDA · drug codes and approvalFederal regulation · registration and approvalRead dates as part of the answer
The national price observations here were checked September 26, 2026. Several offers in that record had terms ending December 31, 2026. Those dates do not establish the price after the stated terms end. Legal and policy records need dates too. The HHS notice published October 30, 2026 describes a draft, nonbinding compounding policy, meaning it does not create a legal right to compound; it is not an FDA approval. A source's event and its limits belong with a claim rather than in a detached footnote.
- Ask whether the document describes an existing rule, a proposal, an agency intention, or a completed approval. Keep the words distinct.
- If a service relies on a newer document, request its title and date. Read the key condition rather than only a summary headline.
- For a price, request a current written quote for the actual product and care. A dated observation is context for that request.
Source notes
The source below supports the point above, within its stated limits.
Federal Register · HHS draft noticeKeep uncertainty visible
FDA describes warning letters as records that may be affected by later exchanges with the recipient. A letter is therefore a dated allegation rather than a final court finding. A medicine-problem report also leaves the question of cause open. These source limits were recorded September 17, 2026. Ask what kind of evidence you are reading before drawing a conclusion that the source itself does not make.
- Keep an unanswered coverage or cost question marked as unanswered. Do not replace it with an estimate from a differently described offer.
- Open Source notes below a section to return to the key public document. Read what it covers alongside the claim.
- Bring a confusing claim to the clinician, pharmacist, insurer, or relevant state office. Ask for a direct answer to the specific question rather than a broad assurance.
- Save the specific document or reply that answers your question. When the proposed product, service, or coverage changes, ask whether that answer still applies. Keeping a source attached to its scope makes the next conversation shorter and the remaining uncertainty easier to name.
Source notes
The source below supports the point above, within its stated limits.
FDA · letter database and its limitsFDA · reports and their limits